Mukesh Verma|NIH|USA| Metabolomics 2015 | Conference Series LLC
4th International Conference and Exhibition on Metabolomics April 27-29, 2015 Philadelphia, USA
Scientific Talk On: Challenges and research opportunities in metabolomics
Click here for Abstract and Biography:http://metabolomicsconference.com/abstract/2015/challenges-and-research-opportunities-in-metabolomics
Mukesh Verma is a Program Director and Chief in the Methods and Technologies Branch (MTB), Epidemiology and Genetics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), National Institutes of Health (NIH). Before coming to the DCCPS, he was a Program Director in the Division of Cancer. Prevention (DCP), NCI, providing direction in the areas of biomarkers, early detection, risk assessment and prevention of cancer, and cancers associated with infectious agents. He holds an MSc from Pantnagar University and a PhD from Banaras Hindu University. He did Postdoctoral research at George Washington University and was a faculty member at Georgetown University. He has published 136 research articles and reviews and edited three books in cancer epigenetics and epidemiology field.
Epidemiology, the study of frequency, distribution, and determinants of disease in human population has gained awareness of its contribution in the advancement of biomedical knowledge over the past several decades. Epidemiologic studies not only offer the opportunities to generate hypotheses through the descriptive nature of the study design, but also provide chances to extrapolate the knowledge gained from laboratory experiments to human and generalize the finding from clinical trials to the general population. Through the course of epidemiologic study design, the hypotheses can be verified for primary prevention strategies and the secondary and tertiary prevention efforts can be evaluated for its effectiveness and efficiency.Although success has been achieved in metabolomic studies, few challenges and research opportunities have come across. One of the challenges of applying metabolomics in epidemiologic studies is to differentiate environmental influences on the metabolome from normal aging of the metabolome which in itself can be associated with age-related illness, such as cancer, diabetes mellitus, and cardiovascular diseases. Additionally, environmental exposures play an important role in shaping the metabolomic signatures, hence can have a significant contribution to epidemiologic studies in understanding its role in disease causation. Population-based studies are an excellent tool to better understand the relationship between metabolomic variations and disease distribution.Epidemiologist employs a number of different study designs (cross-sectional studies, retrospective case-control studies, cohort studies, nested case control studies, intervention studies, family-based studies, birth cohorts) that can be used to study the role of metabolomics in health and diseases.
Conference Series LLC (3000+ Global Events): conferenceseries.com
Global Medical Conferences: conferenceseries.com
Global Nursing Conferences: nursingconference.com
Global Pharmaceutical Conferences: pharmaceuticalconferences.com
Global Cancer Conferences: cancersummit.org
Global Diabetes Conferences: diabetesexpo.com
Global Dental Conferences: dentalcongress.com
700+ Open Access Journals: omicsonline.org